Becker's Healthcare December 3, 2024
Walgreens is facing significant challenges in its primary care strategy.
In 2021, the company acquired a majority stake in VillageMD through a $5.2 billion deal, but it is now reconsidering that strategy — mirroring other large chains’ struggle to break into primary care. According to an Aug. 7 Securities and Exchange Commission filing, Walgreens is evaluating options for VillageMD, including a potential sale of all or part of its stake, as well as restructuring alternatives.
Walgreens is evaluating options for VillageMD, including a potential sale of all or part of its stake, as well as restructuring alternatives.
Walgreens is “currently evaluating a variety of options with respect to VillageMD in light of ongoing investments by the company in VillageMD’s businesses...
Today's Sponsors
Today's Sponsor